INS and obesity disorder: Specifically, studies on Bag-1 and MK-5046 have demonstrated that these compounds stimulate an increase in glucose-mediated insulin secretion in insulinoma cell lines (INS-1 832/3 and MIN6), and in vivo, they also exert several anti-obesity effects (9,13,15,16).